Nevertheless, further work is needed to confirm if trunSM can fulfil the suite of other cancer-related functions reported for SM, such as activation of ERK signaling (e.g. (50)) and interactions with carbonic anhydrase 3 (51), GSK3β, and p53 (52). This evidence concerns the gene TP53 and cancer.